相似文献
1
Dengue virus life cycle: viral and host factors modulating infectivity.
Cell Mol Life Sci. 2010 Aug;67(16):2773-86. doi: 10.1007/s00018-010-0357-z. Epub 2010 Apr 6.
2
Early dengue virus interactions: the role of dendritic cells during infection.
Virus Res. 2016 Sep 2;223:88-98. doi: 10.1016/j.virusres.2016.07.001. Epub 2016 Jul 2.
3
Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules.
mBio. 2017 Aug 1;8(4):e00741-17. doi: 10.1128/mBio.00741-17.
4
The battle between infection and host immune responses of dengue virus and its implication in dengue disease pathogenesis.
ScientificWorldJournal. 2013;2013:843469. doi: 10.1155/2013/843469. Epub 2013 Feb 10.
5
Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection.
mSphere. 2019 Sep 18;4(5):e00528-19. doi: 10.1128/mSphere.00528-19.
6
Antibodies determine virulence in dengue.
Ann N Y Acad Sci. 2009 Sep;1171 Suppl 1:E48-56. doi: 10.1111/j.1749-6632.2009.05052.x.
7
Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.
Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):1939-44. doi: 10.1073/pnas.1317350111. Epub 2014 Jan 2.
8
Dengue virus infects macrophages and dendritic cells in a mouse model of infection.
J Infect Dis. 2007 Jun 15;195(12):1808-17. doi: 10.1086/518007. Epub 2007 May 9.
9
Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
Antiviral Res. 2014 Sep;109:132-40. doi: 10.1016/j.antiviral.2014.07.002. Epub 2014 Jul 11.
10
Phenotypic characterization of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome.
Virol J. 2011 Aug 11;8:398. doi: 10.1186/1743-422X-8-398.
引用本文的文献
1
Deep Generative Models for the Discovery of Antiviral Peptides Targeting Dengue Virus: A Systematic Review.
Int J Mol Sci. 2025 Jun 26;26(13):6159. doi: 10.3390/ijms26136159.
2
DENV-2 Circulation and Host Preference Among Highly Anthropophilic, Outdoor-Biting in Dar es Salaam, Tanzania.
Viruses. 2025 Jun 5;17(6):818. doi: 10.3390/v17060818.
3
Recent advances in the control of dengue fever using herbal and synthetic drugs.
Heliyon. 2025 Jan 18;11(3):e41939. doi: 10.1016/j.heliyon.2025.e41939. eCollection 2025 Feb 15.
4
Pathogenesis and clinical management of arboviral diseases.
World J Virol. 2025 Mar 25;14(1):100489. doi: 10.5501/wjv.v14.i1.100489.
5
Cytoplasmic retention of dengue virus capsid protein by metformin impairing nuclear transport.
J Gen Virol. 2025 Mar;106(3). doi: 10.1099/jgv.0.002089.
6
Nano-interventions for dengue: a comprehensive review of control, detection and treatment strategies.
Inflammopharmacology. 2025 Mar;33(3):979-1011. doi: 10.1007/s10787-025-01655-8. Epub 2025 Feb 20.
7
Urgent Alert: Potential Risk of Dengue Infection Transmission Through Blood Transfusion in Iran.
Arch Iran Med. 2024 Dec 1;27(12):693-699. doi: 10.34172/aim.31756.
8
Unraveling the Molecular Mechanisms of Mosquito Salivary Proteins: New Frontiers in Disease Transmission and Control.
Biomolecules. 2025 Jan 8;15(1):82. doi: 10.3390/biom15010082.
9
Dengue virus infection: how platelet-leukocyte crosstalk shapes thrombotic events and inflammation.
Mol Biol Rep. 2025 Jan 13;52(1):119. doi: 10.1007/s11033-025-10222-x.
10
In Vitro Evaluation of the Anti-Chikungunya Virus Activity of an Active Fraction Obtained from Latex.
Viruses. 2024 Dec 17;16(12):1929. doi: 10.3390/v16121929.
本文引用的文献
1
Immature dengue virus: a veiled pathogen?
PLoS Pathog. 2010 Jan;6(1):e1000718. doi: 10.1371/journal.ppat.1000718. Epub 2010 Jan 8.
2
Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis.
Curr Top Microbiol Immunol. 2010;338:83-98. doi: 10.1007/978-3-642-02215-9_7.
3
T lymphocyte responses to heterologous secondary dengue virus infections.
Ann N Y Acad Sci. 2009 Sep;1171 Suppl 1:E36-41. doi: 10.1111/j.1749-6632.2009.05055.x.
4
Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody.
EMBO J. 2009 Oct 21;28(20):3269-76. doi: 10.1038/emboj.2009.245. Epub 2009 Aug 27.
5
Phenotypic analysis of dengue virus isolates associated with dengue fever and dengue hemorrhagic fever for cellular attachment, replication and interferon signaling ability.
Virus Res. 2009 Oct;145(1):31-8. doi: 10.1016/j.virusres.2009.05.016. Epub 2009 Jun 21.
6
Alternative infectious entry pathways for dengue virus serotypes into mammalian cells.
Cell Microbiol. 2009 Oct;11(10):1533-49. doi: 10.1111/j.1462-5822.2009.01345.x. Epub 2009 Jun 11.
7
A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes.
PLoS Pathog. 2009 May;5(5):e1000453. doi: 10.1371/journal.ppat.1000453. Epub 2009 May 29.
8
Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease.
Infect Genet Evol. 2009 Jul;9(4):523-40. doi: 10.1016/j.meegid.2009.02.003. Epub 2009 Feb 13.
9
Pathogenesis of flavivirus infections: using and abusing the host cell.
Cell Host Microbe. 2009 Apr 23;5(4):318-28. doi: 10.1016/j.chom.2009.04.001.
10
Immunological serotype interactions and their effect on the epidemiological pattern of dengue.
Proc Biol Sci. 2009 Jul 22;276(1667):2541-8. doi: 10.1098/rspb.2009.0331. Epub 2009 Apr 15.
Zotero 插件